Terumo has received the device for evaluation.However, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.H6: component code: 4739 - gas exchanger.Health effect - impact code: 2645 - no patient involvement.Heatlh effect - clinical code: 4582 - no clinical signs, symptoms or conditions.Medical device problem code: 2183 - fitting problem.Investigation findings: 3233 - results pending completion of investigation.Investigation conclusions: 11 - conclusion not yet available.
|
The user facility reported to terumo cardiovascular that during out of box, they noticed the oxygenator was not properly attached to the reservoir bracket when opened.Additionally, the customer tried to push the oxygenator into the reservoir grove and could not advance the oxygenator to secure it to the reservoir.No patient involvement.
|
This follow-up report is submitted to fda in accord with applicable regulations¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on june 22, 2023.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - updated lot number and added expiration date).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information and device evaluation).H3 (device evaluated by manufacturer).H4 (device manufacture date).H6 (identification of evaluation codes 10, 11, 3331, 706, 25).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #3: 3331 - analysis of production records.Investigation findings: 706 - assembly problem identified.Investigation conclusions: 25 - cause traced to manufacturing.The returned sample was visually inspected upon receipt and confirmed that the oxygenator was not properly seated in the support arm.A representative retention sample was inspected and noted to not have any anomalies with the device.A training was conducted with the production associates to make them aware of this event and to ensure that all components, are properly assembled and inspected on the reservoir and oxygenator.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|